Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.78ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
EG.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.45ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.37.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.37.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.77ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-12869.4China
FD.4.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FD.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.16.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.16.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.52ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.52ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.27ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.65ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.75ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.75ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.18.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.18.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HP.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HP.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FU.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FU.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EY.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EY.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.31ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used